Clinicopathologic and prognostic relevance of miR-1256 in colorectal cancer: a preliminary clinical study.
CONCLUSIONS: We firstly provided evidence that low miR-1256 expression was associated with the progression of CRC and could be used as a prognostic biomarker for breast cancer. Further studies are needed.
PMID: 30536313 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Drugs & Pharmacology | Statistics | Study